Peptides

DSIP

Also called Delta sleep-inducing peptide, Emideltide

Studied in:Sleep

Educational only, not medical advice. Dosaly reports what has been studied; it isn't a recommendation to use DSIP or any amount of it. Talk to a clinician.

Not approved as a medicine by the FDA or EMA (as of October 2026).

Research applications

  • Slow-wave (delta) sleep (early animal studies)
  • Chronic insomnia (small controlled human studies with inconsistent results)

What studies have looked at, not proven uses.

What it is

DSIP is a small peptide discovered in the 1970s and named for its link to deep sleep in animals. Human sleep studies had mixed results, and how it works is still unclear.

More detail

Delta sleep-inducing peptide (DSIP) is a nine-amino-acid peptide first isolated in the 1970s from the blood of rabbits in induced sleep, and named for its reported ability to increase slow-wave (delta) sleep in those animals. Decades later, its natural role, its receptor and how the body makes it remain unclear. Small controlled studies in the 1980s and early 1990s looked at sleep in people with chronic insomnia, with inconsistent results: one reported clear improvement, while a later double-blind study concluded the effects were weak. Reviews describe many reported effects in animals but little consistent evidence. Recent research on DSIP is limited.

Evidence listed here

  • 2 human studies
  • 1 review

Results from cells and animals often don't carry over to people. How to read peptide research

Molecular info

Class
Nonapeptide
Length
9 amino acids
Sequence
H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH
Research areas
Sleep